|
1
|
Estey E, Hasserjian RP and Döhner H:
Distinguishing AML from MDS: A fixed blast percentage may no longer
be optimal. Blood. 139:323–332. 2022.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Bispo JAB, Pinheiro PS and Kobetz EK:
Epidemiology and etiology of leukemia and lymphoma. Cold Spring
Harb Perspect Med. 10(a034819)2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Rausch C, Rothenberg-Thurley M, Dufour A,
Schneider S, Gittinger H, Sauerland C, Görlich D, Krug U, Berdel
WE, Woermann BJ, et al: Validation and refinement of the 2022
European LeukemiaNet genetic risk stratification of acute myeloid
leukemia. Leukemia. 37:1234–1244. 2023.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Li Y, Yang W, Devidas M, Winter SS,
Kesserwan C, Yang W, Dunsmore KP, Smith C, Qian M, Zhao X, et al:
Germline RUNX1 variation and predisposition to childhood acute
lymphoblastic leukemia. J Clin Invest. 131(e147898)2021.PubMed/NCBI View Article : Google Scholar : (Epub ahead of
print).
|
|
5
|
Voulgaris E, Pentheroudakis G and Pavlidis
N: Cancer and pregnancy: A comprehensive review. Surg Oncol.
20:e175–e185. 2011.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Thomas X: Acute myeloid leukemia in the
pregnant patient. Eur J Haematol. 95:124–136. 2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Zhu D, Tang D, Chai X, Zhang G and Wang Y:
Acute leukemia in pregnancy: A single institutional experience with
21 cases at 10 years and a review of the literature. Ann Med.
53:567–575. 2021.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Ali S, Jones GL, Culligan DJ, Marsden PJ,
Russell N, Embleton ND and Craddock C: British Committee for
Standards in Haematology. Guidelines for the diagnosis and
management of acute myeloid leukaemia in pregnancy. Br J Haematol.
170:487–495. 2015.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Grove CS and Vassiliou GS: Acute myeloid
leukaemia: A paradigm for the clonal evolution of cancer? Dis Model
Mech. 7:941–951. 2014.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Lavudi K, Nuguri SM, Olverson Z,
Dhanabalan AK, Patnaik S and Kokkanti RR: Targeting the retinoic
acid signaling pathway as a modern precision therapy against
cancers. Front Cell Dev Biol. 11(1254612)2023.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Park JH, Qiao B, Panageas KS, Schymura MJ,
Jurcic JG, Rosenblat TL, Altman JK, Douer D, Rowe JM and Tallman
MS: Early death rate in acute promyelocytic leukemia remains high
despite all-trans retinoic acid. Blood. 118:1248–1254.
2011.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Tsuda H, Doi H, Inada T and Shirono K:
Successful treatment of acute promyelocytic leukemia in a pregnant
woman by using all-trans retinoic acid. Rinsho Ketsueki.
35:717–719. 1994.PubMed/NCBI(In Japanese).
|
|
13
|
Sanz MA, Fenaux P, Tallman MS, Estey EH,
Löwenberg B, Naoe T, Lengfelder E, Döhner H, Burnett AK, Chen SJ,
et al: Management of acute promyelocytic leukemia: Updated
recommendations from an expert panel of the European LeukemiaNet.
Blood. 133:1630–1643. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Santolaria A, Perales A, Montesinos P and
Sanz MA: Acute promyelocytic leukemia during pregnancy: A
systematic review of the literature. Cancers (Basel).
12(968)2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Sanz MA, Grimwade D, Tallman MS, Lowenberg
B, Fenaux P, Estey EH, Naoe T, Lengfelder E, Büchner T, Döhner H,
et al: Management of acute promyelocytic leukemia: Recommendations
from an expert panel on behalf of the European LeukemiaNet. Blood.
113:1875–1891. 2009.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Ssenyonga N, Stiller C, Nakata K, Shalkow
J, Redmond S, Bulliard JL, Girardi F, Fowler C, Marcos-Gragera R,
Bonaventure A, et al: Worldwide trends in population-based survival
for children, adolescents, and young adults diagnosed with
leukaemia, by subtype, during 2000-14 (CONCORD-3): Analysis of
individual data from 258 cancer registries in 61 countries. Lancet
Child Adolesc Health. 6:409–431. 2022.PubMed/NCBI View Article : Google Scholar
|
|
17
|
DeRenzo C, Krenciute G and Gottschalk S:
The landscape of CAR T cells beyond acute lymphoblastic leukemia
for pediatric solid tumors. Am Soc Clin Oncol Educ Book.
38:830–837. 2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Chiaretti S, Zini G and Bassan R:
Diagnosis and subclassification of acute lymphoblastic leukemia.
Mediterr J Hematol Infect Dis. 6(e2014073)2014.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Ticku J, Oberoi S, Friend S, Busowski J,
Langenstroer M and Baidas S: Acute lymphoblastic leukemia in
pregnancy: A case report with literature review. Ther Adv Hematol.
4:313–319. 2013.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Farhadfar N, Cerquozzi S, Hessenauer MR,
Litzow MR, Hogan WJ, Letendre L, Patnaik MM, Tefferi A and Gangat
N: Acute leukemia in pregnancy: A single institution experience
with 23 patients. Leuk Lymphoma. 58:1052–1060. 2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Nadeem S, Elahi E, Iftikhar I, Umar S,
Ahsan B, Ahmad U and Bokhari SW: Management of acute lymphoblastic
leukemia during pregnancy: A case report and review of the
literature. Cureus. 16(e52489)2024.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Theodora M, Theofanakis C, Fasoulakis ZN,
Barbarousi D, Daskalakis G and Rodolakis A: EP685 Management of
acute lymphoblastic leukemia in a 26-year-old primigravida. Int J
Gynecol Cancer. 29 (Suppl 4):A392.3–A393. 2019.
|
|
23
|
Vlijm-Kievit A, Jorna NGE, Moll E, Pajkrt
E, Pals ST, Middeldorp S, Biemond BJ, Zeerleder SS, Tio MA, Kemper
EM and Hazenberg MD: Acute lymphoblastic leukemia during the third
trimester of pregnancy. Leuk Lymphoma. 59:1274–1276.
2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Romero-Morelos P, González-Yebra AL,
Muñoz-López D, Lara-Lona E and González-Yebra B: Frequencies of
BCR::ABL1 transcripts in patients with chronic myeloid leukemia: A
meta-analysis. Genes (Basel). 15(232)2024.PubMed/NCBI View Article : Google Scholar
|
|
25
|
American Cancer Society: Risk Factors for
Chronic Myeloid Leukemia. https://www.cancer.org/cancer/types/chronic-myeloid-leukemia/causes-risks-prevention/risk-factors.html.
|
|
26
|
Zhao D, Long X and Wang J:
Pharmacovigilance study of BCR-ABL1 tyrosine kinase inhibitors: A
safety analysis of the FDA adverse event reporting system. BMC
Pharmacol Toxicol. 25(20)2024.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Brehme M, Koschmieder S, Montazeri M,
Copland M, Oehler VG, Radich JP, Brümmendorf TH and Schuppert A:
Combined population dynamics and entropy modelling supports patient
stratification in chronic myeloid leukemia. Sci Rep.
6(24057)2016.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Xue M, Wang Q, Huo L, Wen L, Yang X, Wu Q,
Pan J, Cen J, Ruan C, Wu D and Chen S: Clinical characteristics and
prognostic significance of chronic myeloid leukemia with rare
BCR-ABL1 transcripts. Leuk Lymphoma. 60:3051–3057. 2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Yadav U, Solanki SL and Yadav R: Chronic
myeloid leukemia with pregnancy: Successful management of pregnancy
and delivery with hydroxyurea and imatinib continued till delivery.
J Cancer Res Ther. 9:484–486. 2013.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Pye SM, Cortes J, Ault P, Hatfield A,
Kantarjian H, Pilot R, Rosti G and Apperley JF: The effects of
imatinib on pregnancy outcome. Blood. 111:5505–5508.
2008.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Abruzzese E, Mauro M, Apperley J and
Chelysheva E: Tyrosine kinase inhibitors and pregnancy in chronic
myeloid leukemia: Opinion, evidence, and recommendations. Ther Adv
Hematol. 11(2040620720966120)2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Soverini S, De Benedittis C, Mancini M and
Martinelli G: Best practices in chronic myeloid leukemia monitoring
and management. Oncologist. 21:626–633. 2016.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Zhang S and Kipps TJ: The pathogenesis of
chronic lymphocytic leukemia. Annu Rev Pathol. 9:103–118.
2014.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Kipps TJ, Stevenson FK, Wu CJ, Croce CM,
Packham G, Wierda WG, O'Brien S, Gribben J and Rai K: Chronic
lymphocytic leukaemia. Nat Rev Dis Primers. 3(16096)2017.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Rogers A and Woyach JA: BTK inhibitors and
anti-CD20 monoclonal antibodies for treatment-naive elderly
patients with CLL. Ther Adv Hematol.
11(2040620720912990)2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Hamad N, Kliman D, Best OG, Caramins M,
Hertzberg M, Lindeman R, Porter R and Mulligan SP: Chronic
lymphocytic leukaemia, monoclonal B-lymphocytosis and pregnancy:
Five cases, a literature review and discussion of management. Br J
Haematol. 168:350–360. 2015.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Hallek M, Cheson BD, Catovsky D,
Caligaris-Cappio F, Dighiero G, Döhner H, Hillmen P, Keating MJ,
Montserrat E, Rai KR, et al: Guidelines for the diagnosis and
treatment of chronic lymphocytic leukemia: a report from the
International workshop on chronic lymphocytic leukemia updating the
national cancer institute-working group 1996 guidelines. Blood.
111:5446–5456. 2008.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Luttwak E, Gurevich-Shapiro A, Azem F,
Lishner M, Klieger C, Herishanu Y, Perry C and Avivi I: Novel
agents for the treatment of lymphomas during pregnancy: A
comprehensive literature review. Blood Rev.
49(100831)2021.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Daver N, Nazha A, Kantarjian HM, Haltom R
and Ravandi F: Treatment of hairy cell leukemia during pregnancy:
Are purine analogues and rituximab viable therapeutic options. Clin
Lymphoma Myeloma Leuk. 13:86–89. 2013.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Cannon T, Mobarek D, Wegge J and Tabbara
IA: Hairy cell leukemia: Current concepts. Cancer Invest.
26:860–865. 2008.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Munir F, Hardit V, Sheikh IN, AlQahtani S,
He J, Cuglievan B, Hosing C, Tewari P and Khazal S: Classical
Hodgkin lymphoma: from past to future-A comprehensive review of
pathophysiology and therapeutic advances. Int J Mol Sci.
24(10095)2023.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Mazharul M: Complications and
Pathophysiology of Hodgkin Lymphoma. J Hematol Thrombo Dis.
10(515)2023.
|
|
43
|
American Cancer Society: Hodgkin Lymphoma
Risk Factors, Risk Factors for Hodgkin Disease. https://www.cancer.org/cancer/types/hodgkin-lymphoma/causes-risks-prevention/risk-factors.html.
|
|
44
|
Smith LH, Danielsen B, Allen ME and Cress
R: Cancer associated with obstetric delivery: Results of linkage
with the California cancer registry. Am J Obstet Gynecol.
189:1128–1135. 2003.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Connors JM: Clinical manifestations and
natural history of Hodgkin's lymphoma. Cancer J. 15:124–128.
2009.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Bachanova V and Connors JM: Hodgkin
lymphoma in pregnancy. Curr Hematol Malig Rep. 8:211–217.
2013.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Gurevich-Shapiro A and Avivi I: Current
treatment of lymphoma in pregnancy. Expert Rev Hematol. 12:449–459.
2019.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Borchmann P, Eichenauer DA and Engert A:
State of the art in the treatment of Hodgkin lymphoma. Nat Rev Clin
Oncol. 9:450–459. 2012.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Ciccarone M, Cavaceppi P, Tesei C,
Brunetti S, Pulsoni A, Annibali O, Gasparoli C, Battistini R,
Hohaus S, Pelliccia S, et al: Effects of ABVD chemotherapy on
ovarian function: Epidemiology, hormonal dosages and ultrasound
morphologic analyses in 270 patients with Hodgkin's disease. Front
Oncol. 13(1059393)2023.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Armitage JO, Gascoyne RD, Lunning MA and
Cavalli F: Non-Hodgkin lymphoma. Lancet. 390:298–310.
2017.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Jiang L and Li N: B-cell non-Hodgkin
lymphoma: Importance of angiogenesis and antiangiogenic therapy.
Angiogenesis. 23:515–529. 2020.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Gequelin LCF, Riediger IN, Nakatani SM,
Biondo AW and Bonfim CM: Epstein-Barr virus: General factors,
virus-related diseases and measurement of viral load after
transplant. Rev Bras Hematol Hemoter. 33:383–388. 2011.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Câmara AB and Brandão IA: The non-Hodgkin
lymphoma treatment and side effects: A systematic review and
meta-analysis. Recent Pat Anticancer Drug Discov: Jan 17, 2023
(Epub ahead of print).
|
|
54
|
Mohseni S, Shojaiefard A, Khorgami Z,
Alinejad S, Ghorbani A and Ghafouri A: Peripheral lymphadenopathy:
Approach and diagnostic tools. Iran J Med Sci. 39 (2
Suppl):S158–S170. 2014.PubMed/NCBI
|
|
55
|
Pirosa MC and Peccatori FA: Lymphomas in
pregnancy. Hematol Oncol. 41 (Suppl 1):S70–S74. 2023.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Dunleavy K and McLintock C: How I treat
lymphoma in pregnancy. Blood. 136:2118–2124. 2020.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Evens AM, Advani R, Press OW, Lossos IS,
Vose JM, Hernandez-Ilizaliturri FJ, Robinson BK, Otis S, Nadav
Dagan L, Abdallah R, et al: Lymphoma occurring during pregnancy:
Antenatal therapy, complications, and maternal survival in a
multicenter analysis. J Clin Oncol. 31:4132–4139. 2013.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Nooh MM, Rizk SM, Saied NM and Abdelazim
SM: Carnosine remedial effect on fertility of male rats receiving
cyclophosphamide, hydroxydaunomycin, oncovin and prednisone (CHOP).
Andrologia. 53(e14233)2021.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Antoine-Pepeljugoski C and Braunstein MJ:
Management of newly diagnosed elderly multiple myeloma patients.
Curr Oncol Rep. 21(64)2019.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Ribourtout B and Zandecki M: Plasma cell
morphology in multiple myeloma and related disorders. Morphologie.
99:38–62. 2015.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Michels TC and Petersen KE: Multiple
myeloma: Diagnosis and treatment. Am Fam Physician. 95:373–383.
2017.PubMed/NCBI
|
|
62
|
Landgren O, Gridley G, Turesson I,
Caporaso NE, Goldin LR, Baris D, Fears TR, Hoover RN and Linet MS:
Risk of monoclonal gammopathy of undetermined significance (MGUS)
and subsequent multiple myeloma among African American and white
veterans in the United States. Blood. 107:904–906. 2006.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Kyle RA and Rajkumar SV: Multiple myeloma.
N Engl J Med. 351:1860–1873. 2004.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Kyle RA and Rajkumar SV: Multiple myeloma.
Blood. 111:2962–2972. 2008.PubMed/NCBI View Article : Google Scholar
|
|
65
|
International Myeloma Working Group.
Criteria for the classification of monoclonal gammopathies,
multiple myeloma and related disorders: A report of the
international myeloma working group. Br J Haematol. 121:749–757.
2003.PubMed/NCBI
|
|
66
|
Kristinsson SY, Minter AR, Korde N, Tan E
and Landgren O: Bone disease in multiple myeloma and precursor
disease: Novel diagnostic approaches and implications on clinical
management. Expert Rev Mol Diagn. 11:593–603. 2011.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Regelink JC, Minnema MC, Terpos E,
Kamphuis MH, Raijmakers PG, Pieters-van den Bos IC, Heggelman BGF,
Nievelstein RJ, Otten RHJ, van Lammeren-Venema D, et al: Comparison
of modern and conventional imaging techniques in establishing
multiple myeloma-related bone disease: A systematic review. Br J
Haematol. 162:50–61. 2013.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Rajkumar SV: MGUS and smoldering multiple
myeloma: Update on pathogenesis, natural history, and management.
Hematology Am Soc Hematol Educ Program. 2005:340–345.
2005.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Greipp PR, San Miguel J, Durie BG, Crowley
JJ, Barlogie B, Bladé J, Boccadoro M, Child JA, Avet-Loiseau H,
Kyle RA, et al: International staging system for multiple myeloma.
J Clin Oncol. 23:3412–3420. 2005.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Elgabry G, Spencer L, Siddiqi H, Ojha S
and Wandroo F: A report of a symptomatic progressive myeloma during
pregnancy and postpartum period from asymptomatic state. Hematol
Rep. 15:305–311. 2023.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Rizack T, Mega A, Legare R and Castillo J:
Management of hematological malignancies during pregnancy. Am J
Hematol. 84:830–841. 2009.PubMed/NCBI View Article : Google Scholar
|
|
72
|
de Montalembert M, Ferster A, Colombatti
R, Rees DC and Gulbis B: European Network for Rare and Congenital
Anaemias. ENERCA clinical recommendations for disease management
and prevention of complications of sickle cell disease in children.
Am J Hematol. 86:72–75. 2011.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Kinoshita S, Yamashita K, Iwatsuki M, Sato
H, Matsumoto C, Matsumoto T, Shiraishi Y, Yoshida N and Baba H:
Disseminated carcinomatosis of the bone marrow from gastric cancer
during pregnancy. Clin J Gastroenterol. 12:447–452. 2019.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Sakamoto K, Kanda T, Ohashi M, Kurabayashi
T, Serikawa T, Matsunaga M and Hatakeyama K: Management of patients
with pregnancy-associated gastric cancer in Japan: A mini-review.
Int J Clin Oncol. 14:392–396. 2009.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Song MJ, Park YS, Song HJ, Park SJ, Ahn
JY, Choi KD, Lee GH, Jung HY, Yook JH and Kim BS: Prognosis of
pregnancy-associated gastric cancer: An age-, sex-, and
stage-matched case-control study. Gut Liver. 10:731–738.
2016.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Milojkovic D and Apperley JF: How I treat
leukemia during pregnancy. Blood. 123:974–984. 2014.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Krashin E and Lishner M: Managing leukemia
during pregnancy. In: Azim H Jr (ed). Managing Cancer during
Pregnancy. Springer, Cham, pp175-184, 2016.
|
|
78
|
Van Calsteren K, Verbesselt R, Beijnen J,
Devlieger R, De Catte L, Chai DC, Van Bree R, Heyns L, de Hoon J
and Amant F: Transplacental transfer of anthracyclines,
vinblastine, and 4-hydroxy-cyclophosphamide in a baboon model.
Gynecol Oncol. 119:594–600. 2010.PubMed/NCBI View Article : Google Scholar
|
